Cartrol en es it fr

Cartrol Brand names, Cartrol Analogs

Cartrol Brand Names Mixture

  • No information avaliable

Cartrol Chemical_Formula


Cartrol RX_link

Cartrol fda sheet

Cartrol msds (material safety sheet)

Cartrol Synthesis Reference

No information avaliable

Cartrol Molecular Weight

292.373 g/mol

Cartrol Melting Point

No information avaliable

Cartrol H2O Solubility

No information avaliable

Cartrol State


Cartrol LogP


Cartrol Dosage Forms

Ophthalmic Solution (1%)

Cartrol Indication

For the treatment of intraocular hypertension and chronic open-angle glaucoma

Cartrol Pharmacology

Carteolol is a beta1 and beta2 (non-selective) adrenergic receptor-blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity. Carteolol, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of glaucomatous visual field loss and optic nerve damage. Carteolol reduces intraocular pressure with little or no effect on pupil size or accommodation in contrast to the miosis which cholinergic agents are known to produce.

Cartrol Absorption

No information avaliable

Cartrol side effects and Toxicity

The most common effects expected with overdosage of a beta-adrenergic blocking agent are bradycardia, bronchospasm, congestive heart failure and hypotension.

Cartrol Patient Information

No information avaliable

Cartrol Organisms Affected

Humans and other mammals